Global Anastomosis Devices Market By Product Type (Disposable and Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), By End-user (Hospitals, Ambulatory Care Centers & Clinics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Anastomosis Devices Market Overview:

The market for anastomosis devices worldwide was worth USD 3,980 million in 2021. This is expected to increase at a compound annual growth rate (CAGR) of 5.8% between 2023-2032.

Global Anastomosis Devices Market:

Product Type Analysis

The disposable segment had the largest revenue share, at over 88.0%, in 2021. This was due to the greater market penetration and availability of disposable anastomotic products. A majority of key players are involved with the production of disposable products.

Surgical Site Infections, cross-contamination, and other Healthcare-Associated Infections are all reduced by using these products (HAI). The fact that disposable anastomotic devices do not need to be reprocessed between usage gives them an advantage over reusable devices. This reduces the amount of time and money spent on reprocessing. The aforementioned benefits are projected to contribute to this segment’s robust growth.

A new segment in the anastomosis market is the reusable anastomotic instrument. The segment is expected to see a substantial CAGR over the forecast. The development of technologically-advanced products and the rising need to reduce biomedical waste are some of the key factors anticipated to fuel the growth of the segment in the forthcoming years.

Application Analysis

Cardiovascular surgery held a significant revenue share in 2021. According to the WHO, 17.9 million people died due to Cardiovascular Diseases in 2019. The rise in CVD prevalence is contributing to an increase in heart surgeries, such as CABG.

The segment of gastrointestinal surgery, which includes colorectal surgery and large bowel removals, will see tremendous growth in the future. This is due to an increasing number of colorectal cancer cases and other gastrointestinal diseases that require bowel dissection. According to the American Cancer Society in 2020, there will be an estimated 104,610 new cases of colon cancer in the U.S. and 43,340 cases of rectal carcinoma in the U.S.

Asia Pacific’s colorectal Cancer is on the rise. The anastomosis market has tremendous potential. According to the report, East Asian countries such as China, South Korea, Singapore, and Japan have experienced a two to fourfold rise in colorectal cancer incidences over the last decade. The market will see a significant increase in products for gastrointestinal anastomosis over the next few years, which could provide a profitable growth opportunity.

End-User Analysis

In 2021, hospitals held a great revenue share. Hospitals provide superior care for patients, which is why they are seeing a lot of growth. According to the American heart association, by 2030, nearly 23.6 million patients will be admitted to the hospital with cardiovascular conditions. This segment is driven by many factors including the growing number of patients visiting hospitals due to accessibility to treatment and proper reimbursement.

The fastest projected CAGR for the ambulatory clinics & centers segment is 3.5% over the forecast period. Due to its cost-effectiveness and non-hospital stay requirements, there is likely a growing preference for outpatient healthcare. In the coming years, the growth of the sector is also expected to be driven primarily by government initiatives and increased funding for ambulatory healthcare facilities.

Key Segment Analysis:

Product Type

• Disposable
• Reusable

Application

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

End-user

• Hospitals
• Ambulatory Care Centers & Clinics

Market Dynamics:

The key trends driving the market growth are rising surgical procedures, as well as the rising prevalence of cardiovascular and gastrointestinal diseases. The COVID-19 epidemic has significantly impacted the surgical practice. The general surgery practice has been affected by the pandemic. The pandemic has had major implications on the way that general surgery practice works, including open vs. nominally invasive surgical techniques, patient safety, staff safety, and theatre workflow. All specialties must consider the importance and possible non-surgical management options. Many elective or semi-elective surgeries, including those involving gastrointestinal malignancies and other issues, have been suspended. However, these surgeries will soon be in full force and the market will respond accordingly.

In addition, market growth is driven by patient satisfaction and the adoption of new anastomosis device innovations. India Medtronic Private Limited (a wholly-owned subsidiary) introduced the EEA circular stapler with Tri-Staple Technology. This is the first 3-row Circular Stapler that has wide-ranging height staples and is intended for use in colorectal surgery.

In developed nations, favorable reimbursement circumstances for cardiac treatments, as well as the launch of technologically improved goods, such as Coronary Bypass Graft Surgery, open-heart valve replacement, and angioplasty, are driving the market for anastomosis devices. Medicare Part B is a Medicare program that covers cardiac rehabilitation (CR), including valve repair & substitution, coronary artery bypass graft, and angioplasty.

Regional Analysis:

North America had the largest revenue share at 40.0% in 2021. The region’s growing market is expected to be stimulated by the rising prevalence of cardiovascular diseases as well as the increasing number of R&D partnerships between major players. Key factors driving the growth include increasing access to medical care, raising awareness about CVD/CHD, rising disposable income, and well-established R&D infrastructure.

Asia Pacific (APAC), will likely register the highest CAGR for the forecast period. APAC’s key players are India, China, and Japan. Due to improved economic conditions, rising healthcare awareness, and an aging population, the APAC market will experience the greatest growth. This is a target population that is more vulnerable to heart and stomach diseases.

This market is expected to grow due to the increasing interest of companies in expanding their presence in the region and the growing demand for anastomosis devices. Regional market growth is being driven by increasing R&D and rising healthcare expenditure.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market share Analysis:

Key players are involved in many strategies including mergers and acquisitions, new product development, collaborations, and partnerships, as well as expansion strategies to increase their market penetration. Vascular Graft Solutions Ltd., for example, received FDA marketing authorization in March 2021. This new device is for clampless proximal ossification in CABG.

Key Market Players:

• Medtronic
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Peters Surgical
• LivaNova PLC
• Ethicon US LLC
• Synovis Micro Companies Alliance Inc.
• Other Key Players

For the Global Anastomosis Devices Market research study, the following years have been considered to estimate the market size: